Idera Phama (IDP) Discloses Two Positive Presentations of its TLR9 Agonists
Tweet Send to a Friend
Idera Pharmaceuticals, Inc. (AMEX: IDP) announced two presentations of data for two new potential applications in oncology of its novel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


